Terns Pharmaceuticals

About

Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.

Foster City,California,United States
11 - 50
https://ternspharma.com/

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $86.30M
Industries: Biotechnology,Health Care,Medical,Medical Device,Pharmaceutical
Founded date: Jan 1, 2016
Number Of Employee: 11 - 50
Operating Status: Active
Stock Symbol: nasdaq:TERN
Legal Name: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.
The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets.
Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$475.80M

Terns Pharmaceuticals has raised a total of $475.80M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 20, 2022	Post-IPO Equity	$86.30M	—	—	—	Detail
Aug 12, 2022	Post-IPO Equity	$65M	2	Fairmount Funds Management Venrock Healthcare Capital Partners	—	Detail
Feb 4, 2021	IPO	$127.50M	—	—	—	Detail
Jan 5, 2021	Series C	$87M	7	Deepfield Eli Lilly	—	Detail
Oct 30, 2018	Series B	$80M	4	OrbiMed Vivo Capital	—	Detail

Investments

Number of Investments

Number of Lead Investments

6

0

Terns Pharmaceuticals has made 6 investments. Their most recent investment was on Aug 17, 2021, when 1K Kirana Bazaar raised ₹520M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 17, 2021 1K Kirana Bazaar	Series A	₹520M	Consumer	—
Jul 18, 2021 Captain Fresh	Series A	₹890M	B2B	—
Mar 4, 2021 Agrim Wholesale	Seed	$2.40M	E-Commerce	—
Jan 29, 2021 Saveo	Seed	₹290M	E-Commerce	—
Jul 15, 2020 Captain Fresh	Series A	$12M	B2B	—

Investors

Number of Lead Investors

Number of Investors

7

10

Terns Pharmaceuticals is funded by 10 investors. Fairmount Funds Management and Venrock Healthcare Capital Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Fairmount Funds Management	Yes	Post-IPO Equity
Venrock Healthcare Capital Partners	Yes	Post-IPO Equity
Deepfield	Yes	Series C
Eli Lilly	Yes	Series C
Lilly Asia Ventures	—	Series C
OrbiMed	—	Series C
Samara Capital	—	Series C
Suvretta Capital Management	—	Series C
Vivo Capital	—	Series C
Decheng Capital	—	Series B